Regulatory Efficiency Report | Medicines for Europe

To view the full report, please click here.

IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Review of the SPC Manufacturing Waiver: a First Industry… 13 June 2023 The Supplementary Protection Certificate (SPC) is a sui generis protection…
2022 Health at a Glance Report highlights the need to… 5 December 2022 Over the last two years, major crises have had dramatic…
Access to medicines critical in European Parliament vote on… 12 November 2021 The European Parliament Own Initiative Report on an intellectual property…